Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Atherosclerosis is the major underlying cause of various Cardiovascular diseases (CVDs) including Coronary Artery Disease (CAD), myocardial infarction etc. Inflammation has been demonstrated to play a pivotal role in the genesis of atherosclerosis though its pathogenesis is extremely complicated. Besides implication of inflammation and immune reactions in this process, a wide range of circulating markers of inflammation has also been demonstrated to predict cardiovascular event in a variety of clinical settings. Interleukin-18, a member of the IL-1 superfamily, has several biological activities that initiate and promote host defence and inflammation. There have been several reports relating the up regulation of IL-18 in human inflammatory and autoimmune diseases, including rheumatoid arthritis, type I diabetes, atherosclerosis, chronic heart failure, and idiopathic thrombocytopenic purpura. Clinical and experimental studies have demonstrated an association of elevated IL-18 levels with increased CVD risk.
Source: Interleukin-18 and Atherosclerosis: Mediator or Biomarker
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi